Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant.
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Balances: a New Perspective for Microbiome Analysis.
Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
A Summary of the Third Annual HIV Microbiome Workshop.